| The growing role of precision and personalized medicine for cancer treatment P Krzyszczyk, A Acevedo, EJ Davidoff, LM Timmins, I Marrero-Berrios, ... Technology 6 (03n04), 79-100, 2018 | 856 | 2018 |
| αBB: A global optimization method for general constrained nonconvex problems IP Androulakis, CD Maranas, CA Floudas Journal of Global Optimization 7 (4), 337-363, 1995 | 649 | 1995 |
| A global optimization method, αBB, for general twice-differentiable constrained NLPs—II. Implementation and computational results CS Adjiman, IP Androulakis, CA Floudas Computers & chemical engineering 22 (9), 1159-1179, 1998 | 522 | 1998 |
| Global optimization of mixed‐integer nonlinear problems CS Adjiman, IP Androulakis, CA Floudas AIChE Journal 46 (9), 1769-1797, 2000 | 360 | 2000 |
| Cytoskeleton-based forecasting of stem cell lineage fates MD Treiser, EH Yang, S Gordonov, DM Cohen, IP Androulakis, J Kohn, ... Proceedings of the National Academy of Sciences 107 (2), 610-615, 2010 | 344 | 2010 |
| Molecular structure effects on laminar burning velocities at elevated temperature and pressure JT Farrell, RJ Johnston, IP Androulakis SAE transactions, 1404-1425, 2004 | 238 | 2004 |
| Global optimization of MINLP problems in process synthesis and design CS Adjiman, IP Androulakis, CA Floudas Computers & Chemical Engineering 21, S445-S450, 1997 | 224 | 1997 |
| Metabolomic fingerprinting: challenges and opportunities AK Kosmides, K Kamisoglu, SE Calvano, SA Corbett, I Androulakis Critical Reviews™ in Biomedical Engineering 41 (3), 2013 | 215 | 2013 |
| Solving long-term financial planning problems via global optimization CD Maranas, IP Androulakis, CA Floudas, AJ Berger, JM Mulvey Journal of Economic Dynamics and Control 21 (8-9), 1405-1425, 1997 | 206* | 1997 |
| A global optimization method, αBB, for process design CS Adjiman, IP Androulakis, CD Maranas, CA Floudas Computers & Chemical Engineering 20, S419-S424, 1996 | 201 | 1996 |
| Sepsis: Something old, something new, and a systems view R Namas, R Zamora, R Namas, G An, J Doyle, TE Dick, FJ Jacono, ... Journal of critical care 27 (3), 314. e1-314. e11, 2012 | 198 | 2012 |
| A genetic algorithmic framework for process design and optimization IP Androulakis, V Venkatasubramanian Computers & chemical engineering 15 (4), 217-228, 1991 | 193 | 1991 |
| Analysis of time-series gene expression data: methods, challenges, and opportunities IP Androulakis, E Yang, RR Almon Annu. Rev. Biomed. Eng. 9 (1), 205-228, 2007 | 179 | 2007 |
| Chronopharmacology of glucocorticoids ML Scherholz, N Schlesinger, IP Androulakis Advanced drug delivery reviews 151, 245-261, 2019 | 162 | 2019 |
| Physiologically-based pharmacokinetic models: approaches for enabling personalized medicine C Hartmanshenn, M Scherholz, IP Androulakis Journal of pharmacokinetics and pharmacodynamics 43 (5), 481-504, 2016 | 153 | 2016 |
| Modeling the influence of circadian rhythms on the acute inflammatory response JD Scheff, SE Calvano, SF Lowry, IP Androulakis Journal of theoretical biology 264 (3), 1068-1076, 2010 | 141 | 2010 |
| Identification of a gene regulatory network necessary for the initiation of oligodendrocyte differentiation VA Swiss, T Nguyen, J Dugas, A Ibrahim, B Barres, IP Androulakis, ... PloS one 6 (4), e18088, 2011 | 139 | 2011 |
| Kinetic mechanism reduction based on an integer programming approach IP Androulakis AIChE Journal 46 (2), 361-371, 2000 | 133 | 2000 |
| Assessment of pharmacologic area under the curve when baselines are variable JD Scheff, RR Almon, DC DuBois, WJ Jusko, IP Androulakis Pharmaceutical research 28 (5), 1081-1089, 2011 | 130 | 2011 |
| At the interface of lifestyle, behavior, and circadian rhythms: metabolic implications SA Bae, MZ Fang, V Rustgi, H Zarbl, IP Androulakis Frontiers in nutrition 6, 132, 2019 | 118 | 2019 |